By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Where Your Profits Grow Sky High.

Austrians conduct research in New York on low-priced vaccine

Peter Palese (left) © Icahn School of Medicine at Mount Sinai

The vaccine should cost considerably less than one dollar per dose. The first clinical studies began recently and are taking place in Southeast Asia and Latin America. The scientists led by Peter Palese at the Icahn School of Medicine at Mount Sinai are convinced that its vaccine will be needed, especially in low- and middle-income countries.

Peter Palese, born in Linz, Austria, is Chair of the Departments of Microbiology at the Mount Sinai School of Medicine. In addition to his speciality in influenza viruses, on which he works in cooperation with the Austria virologist Florian Krammer, the scientists also gained experience with the coronavirus last year. Together with Kramer's working group and that of Adolfo Garcia-Sastre, Palese's team is focusing on the development of a vaccine. This comprises a viral vector-based vaccine in which part of the SARS-CoV-2 virus genetic material is introduced into the body via another virus. In this case, the researchers have used the Newcastle disease virus (NDV), which is primarily responsible for triggering the atypical avian influenza which is harmless to people.

In the initial studies, the vaccine showed a good immune response to the new coronavirus. Moreover, the vaccine can be administered through people's noses. This also makes it an interesting option to administer to children. The vaccine can be stored at a normal refrigerator temperature of two to four degrees Celsius.

Continue reading and learn more about life sciences research in Austria!

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin



Meet us at events, seminars and trade shows - worldwide.

  • Austria – Carinthia your ICT Hub in the Heart of Europe

    14.04.2021/ 02.30 pm (India Time) , Online Conference

Austria Map

Find the perfect location for your company

Inspite of higher labor costs, the productivity of Siemens Villach is comparable to other Siemens susidiaries in Japan or the USA.

Siemens Austria

More testimonials

news from the business location Austria

Austrians conduct research in New York on low-priced vaccine

Two Austrians are conducting research in New York on a vaccine against the coronavirus which is designed to be available at a particularly low price and also be easy to dispense.

Support measures for companies affected by COVID-19

To stimulate the economy, either new programs may be established as a result of the draft law or existing support programs (e.g. aws, ÖHT) will be expanded. All measures introduced are intended to be applicable immediately and will be in force until the end of 2020. The measures currently introduced include the following areas:

More news All blog posts